Study protocol for a multicentre, open-label, single-arm phase I/II trial to evaluate the safety and efficacy of ripasudil 0.4% eye drops for retinopathy of prematurity.
Mitsuru ArimaHirosuke InoueShintaro NakaoAkiko MisumiMaya SuzukiItsuka MatsushitaShunsuke ArakiChiemi YamashiroKazumasa TakahashiMasayuki OchiaiNoriko YoshidaMasayuki HiroseJunji KishimotoKoji TodakaShunji HasegawaKazuhiro KimuraKoichi KusuharaHiroyuki KondoShouichi OhgaKoh-Hei SonodaPublished in: BMJ open (2021)
NCT04621136 and jRCT2071200047.